Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 162
of 9Next
1:

B cell non-Hodgkin's lymphoma: rituximab safety experience.

Mohrbacher A.

Arthritis Res Ther. 2005;7 Suppl 3:S19-25. Epub 2005 May 18. Review.

PMID: 15960818 [PubMed - indexed for MEDLINE]

2:

Safety of rituximab in the treatment of B cell malignancies: implications for rheumatoid arthritis.

Hainsworth JD.

Arthritis Res Ther. 2003;5 Suppl 4:S12-6. Epub 2003 Dec 2. Review.

PMID: 15180892 [PubMed - indexed for MEDLINE]

3:

Rituximab: review and clinical applications focusing on non-Hodgkin's lymphoma.

King KM, Younes A.

Expert Rev Anticancer Ther. 2001 Aug;1(2):177-86. Review.

PMID: 12113023 [PubMed - indexed for MEDLINE]

4:

Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.

Cvetković RS, Perry CM.

Drugs. 2006;66(6):791-820. Review.

PMID: 16706552 [PubMed - indexed for MEDLINE]

5:

Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma.

Fanale MA, Younes A.

Drugs. 2007;67(3):333-50. Review.

PMID: 17335294 [PubMed - indexed for MEDLINE]

6:

Maintenance therapy for low-grade lymphomas: has the time come?

Cartron G, Solal-Céligny P.

Curr Opin Oncol. 2007 Sep;19(5):425-32. Review.

PMID: 17762565 [PubMed - indexed for MEDLINE]

7:

Rituximab immunotherapy for non-Hodgkin's lymphoma.

White CA.

Cancer Biother Radiopharm. 1999 Aug;14(4):241-50. Review.

PMID: 10850310 [PubMed - indexed for MEDLINE]

8:

Panel discussion on B cells and rituximab: mechanistic aspects, efficacy and safety in rheumatoid arthritis and non-Hodgkin's lymphoma.

Panayi GS, Hainsworth JD, Looney RJ, Keystone EC.

Rheumatology (Oxford). 2005 May;44 Suppl 2:ii18-ii20.

PMID: 15851523 [PubMed - indexed for MEDLINE]

9:

Rituximab and its role as maintenance therapy in non-Hodgkin lymphoma.

Collins-Burow B, Santos ES.

Expert Rev Anticancer Ther. 2007 Mar;7(3):257-73. Review.

PMID: 17338647 [PubMed - indexed for MEDLINE]

10:

Rituximab (Rituxan/MabThera): the first decade (1993-2003).

Grillo-López AJ.

Expert Rev Anticancer Ther. 2003 Dec;3(6):767-79. Review.

PMID: 14686699 [PubMed - indexed for MEDLINE]

11:

Rituximab: a new monoclonal antibody therapy for non-Hodgkin's lymphoma.

Kosits C, Callaghan M.

Oncol Nurs Forum. 2000 Jan-Feb;27(1):51-9. Review.

PMID: 10660923 [PubMed - indexed for MEDLINE]

12:

Optimizing the use of rituximab for treatment of B-cell non-Hodgkin's lymphoma: a benefit-risk update.

Kunkel L, Wong A, Maneatis T, Nickas J, Brown T, Grillo-López A, Benyunes M, Grobman B, Dillman RO.

Semin Oncol. 2000 Dec;27(6 Suppl 12):53-61. Review.

PMID: 11226001 [PubMed - indexed for MEDLINE]

13:

Spotlight on rituximab in non-Hodgkin lymphoma and chronic lymphocytic leukemia.

Cvetković RS, Perry CM.

BioDrugs. 2006;20(4):253-7. Review.

PMID: 16831024 [PubMed - indexed for MEDLINE]

14:

Rituximab.

Onrust SV, Lamb HM, Balfour JA.

Drugs. 1999 Jul;58(1):79-88; discussion 89-90. Review.

PMID: 10439931 [PubMed - indexed for MEDLINE]

15:

[Rituximab in the treatment of indolent non-Hodgkin's lymphoma]

Aurer I, Mitrović Z, Radman I, Kovacević-Metelko J, Nemet D, Serventi-Seiwerth R, Stern-Padovan R, Jakic-Razumović J, Nola M, Zupancić-Salek S, Sertić D, Labar B.

Lijec Vjesn. 2004 Nov-Dec;126(11-12):307-11. Croatian.

PMID: 16082888 [PubMed - indexed for MEDLINE]

16:

Rituximab in lymphoma: a systematic review and consensus practice guideline from Cancer Care Ontario.

Cheung MC, Haynes AE, Meyer RM, Stevens A, Imrie KR; Members of the Hematology, Disease Site Group of the Cancer Care Ontario Program in Evidence-Based Care.

Cancer Treat Rev. 2007 Apr;33(2):161-76. Epub 2007 Jan 22. Review.

PMID: 17240533 [PubMed - indexed for MEDLINE]

17:

Rituximab therapy in hematologic malignancy patients with circulating blood tumor cells: association with increased infusion-related side effects and rapid blood tumor clearance.

Byrd JC, Waselenko JK, Maneatis TJ, Murphy T, Ward FT, Monahan BP, Sipe MA, Donegan S, White CA.

J Clin Oncol. 1999 Mar;17(3):791-5.

PMID: 10071268 [PubMed - indexed for MEDLINE]

18:

Rituximab for treatment of intermediate and aggressive B-cell non-Hodgkin's lymphomas.

[No authors listed]

TEC Bull (Online). 2002 Apr 5;19(1):19-21. No abstract available.

PMID: 12166456 [PubMed - indexed for MEDLINE]

19:

What is the role of rituximab in the treatment of rheumatoid arthritis?

Atzeni F, Doria A, Maurizio T, Sarzi-Puttini P.

Autoimmun Rev. 2007 Sep;6(8):553-8. Epub 2007 Mar 7. Review.

PMID: 17854748 [PubMed - indexed for MEDLINE]

20:

Second treatment with rituximab in B-cell non-Hodgkin's lymphoma: efficacy and toxicity on 41 patients treated at CHU-Lyon Sud.

Lemieux B, Bouafia F, Thieblemont C, Hequet O, Arnaud P, Tartas S, Traulle C, Salles G, Coiffier B.

Hematol J. 2004;5(6):467-71.

PMID: 15570286 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 162
of 9Next